Loading...
Accuray Incorporated
ARAY•NASDAQ
Healthcare
Medical - Specialties
$1.25
$0.03(2.46%)
Accuray Incorporated (ARAY) Financial Performance & Statements
Review Accuray Incorporated’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-0.24%
↓ 0.24%
Operating Income Growth
-78.84%
↓ 78.84%
Net Income Growth
-67.51%
↓ 67.51%
Operating Cash Flow Growth
-176.61%
↓ 176.61%
Operating Margin
2.24%
↑ 2.24%
Gross Margin
31.48%
↑ 31.48%
Net Profit Margin
0.14%
↑ 0.14%
ROE
1.43%
↑ 1.43%
ROIC
3.71%
↑ 3.71%
Accuray Incorporated (ARAY) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Accuray Incorporated stock.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $116.17M | $101.55M | $134.29M | $101.13M |
| Cost of Revenue | $74.28M | $67.08M | $95.84M | $72.06M |
| Gross Profit | $41.89M | $34.47M | $38.45M | $29.07M |
| Gross Profit Ratio | $0.36 | $0.34 | $0.29 | $0.29 |
| R&D Expenses | $13.64M | $12.12M | $9.53M | $10.91M |
| SG&A Expenses | $23.54M | $24.50M | $22.11M | $22.73M |
| Operating Expenses | $37.19M | $36.62M | $31.64M | $33.64M |
| Total Costs & Expenses | $111.47M | $103.69M | $127.47M | $105.69M |
| Interest Income | $278000.00 | $0.00 | $0.00 | $2.65M |
| Interest Expense | $2.88M | $2.96M | $2.90M | $2.88M |
| Depreciation & Amortization | $1.51M | $1.46M | $1.51M | $1.60M |
| EBITDA | $7.63M | $1.09M | $8.32M | -$1.41M |
| EBITDA Ratio | $0.07 | $0.01 | $0.06 | -$0.01 |
| Operating Income | $4.71M | -$2.15M | $6.82M | -$4.56M |
| Operating Income Ratio | $0.04 | -$0.02 | $0.05 | -$0.05 |
| Other Income/Expenses (Net) | -$1.48M | -$1.18M | -$2.96M | -$1.34M |
| Income Before Tax | $3.23M | -$3.33M | $3.86M | -$5.90M |
| Income Before Tax Ratio | $0.03 | -$0.03 | $0.03 | -$0.06 |
| Income Tax Expense | $695000.00 | $625000.00 | $471000.00 | $444000.00 |
| Net Income | $2.54M | -$3.95M | $3.39M | -$6.34M |
| Net Income Ratio | $0.02 | -$0.04 | $0.03 | -$0.06 |
| EPS | $0.03 | -$0.04 | $0.03 | -$0.06 |
| Diluted EPS | $0.02 | -$0.04 | $0.03 | -$0.06 |
| Weighted Avg Shares Outstanding | $101.41M | $100.22M | $99.58M | $99.20M |
| Weighted Avg Shares Outstanding (Diluted) | $103.75M | $100.22M | $101.03M | $99.20M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan